The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sintilimab plus anlotinib as first-line therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC).
 
Xiaofeng Chen
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Xiaofeng Wu
No Relationships to Disclose
 
Fengjiao Zhao
No Relationships to Disclose
 
Deqiang Wang
No Relationships to Disclose
 
Hao Wu
No Relationships to Disclose
 
Yanhong Gu
No Relationships to Disclose
 
Xiao Li
No Relationships to Disclose
 
Xiaofeng Qian
No Relationships to Disclose
 
Jun Hu
No Relationships to Disclose
 
Changxian Li
No Relationships to Disclose
 
Yongxiang Xia
No Relationships to Disclose
 
Jianhua Rao
No Relationships to Disclose
 
Aihua Yao
No Relationships to Disclose
 
Poshita kumari Seesaha
No Relationships to Disclose
 
Qianwen Shao
No Relationships to Disclose
 
XiaoWei Dong
No Relationships to Disclose
 
Xiangcheng Li
No Relationships to Disclose
 
Yongqian Shu
No Relationships to Disclose